Craft

Revance Aesthetics

Revenue

$125.1 M

FY, 2022

Revance Aesthetics Summary

Company Summary

Overview
Revance Aesthetics is a business segment of Revance Therapeutics specializing in aesthetic products. Its portfolio includes DAXXIFY, an injection for the treatment of frown lines, RHA Collection, a collection of resilient hyaluronic acid (HA) fillers, OPUL, a relational commerce platform, and REVANCEU, an injector training and educational platform.
Type
Subsidiary
Status
Active
Founded
2020
Website
https://revanceaesthetics.com/
Sectors

Key People

Revance Aesthetics Financials

Summary Financials

Revenue (FY, 2022)
$125.1M

Footer menu